amgen inc. said 0 its second-quarter earnings increased more than tenfold to $ 3.9 million , or 22 cents a share , due to increased sales of the company 's new antianemia drug for kidney patients . the thousand oaks , calif.-based biotechnology company reported a 97 % increase in revenue to $ 42.5 million for the quarter ended sept. 30 . in the year-ago period , amgen reported net income of $ 320,000 , or two cents a share , on revenue of $ 21.5 million . for the six months , the company reported a more than sixfold increase in earnings to $ 4.7 million , or 26 cents a share , from $ 625,000 , or four cents a share a year ago . revenue rose 77 % to $ 72.6 million , from last year 's $ 41 million .